Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
|
|
TELA Bio, Inc. (TELA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/21/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/22/2022 |
SC 13D/A
| EW HEALTHCARE PARTNERS FUND 2, L.P. reports a 21.4% stake in TELA Bio, Inc. |
| 08/19/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/18/2022 |
SC 13D/A
| EW HEALTHCARE PARTNERS FUND 2, L.P. reports a 24.8% stake in TELA Bio, Inc. |
| 06/01/2022 |
SC 13D/A
| EW HEALTHCARE PARTNERS FUND 2, L.P. reports a 23.7% stake in TELA Bio, Inc. |
| 02/28/2022 |
SC 13D/A
| EW HEALTHCARE PARTNERS FUND 2, L.P. reports a 22.8% stake in TELA Bio, Inc. |
| 01/19/2022 |
SC 13D/A
| EW HEALTHCARE PARTNERS FUND 2, L.P. reports a 17.1% stake in TELA Bio, Inc. |
| 09/21/2021 |
SC 13D/A
| EW HEALTHCARE PARTNERS FUND 2, L.P. reports a 12.7% stake in TELA Bio, Inc. |
| 05/18/2021 |
SC 13D/A
| EW HEALTHCARE PARTNERS FUND 2, L.P. reports a 11.6% stake in TELA Bio, Inc. |
| 07/01/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
|
|